General Pharmaceutical Council determination — substantive hearing
Suspension (suspended from practice) — 3 months
Added to MedicWatch: 5 May 2026Report a correction
What does “suspended from practice” mean?
The regulator imposed a fixed-term suspension in this decision. Its start date, appeal provisions and any later review affect whether it is currently in force. Check the official register for the practitioner's current status.
Concerning Ismail Essop Nagdi, pharmacist (General Pharmaceutical Council 2034553).
Decision date: 22 April 2024 · Hearing started 22 April 2024
In plain English
The GPhC committee decided that Ismail Essop Nagdi should be subject to the published outcome from a principal hearing in a conviction case. The committee imposed a suspension for 3 months. It records fitness to practise as impaired. The official determination gives the committee's reasons, order wording, and any conditions attached to the decision.
Findings
The GPhC Fitness to Practise Committee held a principal hearing for Ismail Essop Nagdi in a conviction case. It records fitness to practise as impaired. The committee imposed a suspension for 3 months.
Source
All facts on this page are drawn from the publicly published General Pharmaceutical Council determination linked below. MedicWatch does not editorialise the regulator’s findings.
Spot something incorrect?
If a fact on this page is wrong, or you believe the page should not be published, please submit a correction or takedown request.